GeneCker

CRISPincette™

01

CRISPR/Cas9
System
02

Liquid Biopsy
03

NGS

CRISPR/Cas9 System

Using an ultra-precision CRISPR/Cas9 system, cancer can be diagnosed with small amounts of blood or Tissue, FFPE by improving the detection limits of genetic variation.

Liquid Biopsy

Instead of complex surgical methods, simple blood collection can swiftly and accurately analyze mutant DNA, and periodic monitoring tests are also possible with simple procedures.

NGS

CRISPincette™ is an NGS (Next-Generation Sequencing)-based cancer diagnostic kit with GeneCker’s ultra-precision CRISPR/Cas9 system.

Using an ultra-precision CRISPR/Cas9 system, cancer can be diagnosed with small amounts of blood or tissue, FFPE
by improving the detection limits of genetic variation.

CRISPincette™